Terms: = Breast cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC
184 results:
1. Inactivation of the Tumor Suppressor cyld Sensitizes Mice to breast cancer Development.
Pseftogas A; Xanthopoulos K; Siasiaridis A; Poutahidis T; Gonidas C; Tsingotjidou A; Hatzivassiliou E; Mosialos G
Anticancer Res; 2024 May; 44(5):1885-1894. PubMed ID: 38677721
[TBL] [Abstract] [Full Text] [Related]
2. Dual functionality of pyrimidine and flavone in targeting genomic variants of EGFR and ER receptors to influence the differential survival rates in breast cancer patients.
Avti PK; Singh J; Dahiya D; Khanduja KL
Integr Biol (Camb); 2023 Apr; 15():. PubMed ID: 38084900
[TBL] [Abstract] [Full Text] [Related]
3. BRCA1/TP53 tumor proteins inhibited by novel analogues of curcumin - Insight from computational modelling, dynamic simulation and experimental validation.
Aloor LJ; Skariyachan S; Raghavamenon AC; Kumar KM; Narayanappa R; Uttarkar A; Niranjan V; Cherian T
Int J Biol Macromol; 2023 Dec; 253(Pt 4):126989. PubMed ID: 37739292
[TBL] [Abstract] [Full Text] [Related]
4. Propolis-loaded nanostructured lipid carriers halt breast cancer progression through miRNA-223 related pathways: an in-vitro/in-vivo experiment.
Shaker SA; Alshufta SM; Gowayed MA; El-Salamouni NS; Bassam SM; Megahed MA; El-Tahan RA
Sci Rep; 2023 Sep; 13(1):15752. PubMed ID: 37735586
[TBL] [Abstract] [Full Text] [Related]
5. Cylindroma of the breast with cyld gene mutation: a case report and review of the literature.
Escher-Michlig V; Vlajnic T; Roma L; Marinucci M; Piscuoglio S; Matter M; Haug M; Weber WP; Muenst S
Mol Biol Rep; 2023 Aug; 50(8):7133-7139. PubMed ID: 37389703
[TBL] [Abstract] [Full Text] [Related]
6. Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal Adenocarcinoma.
Kumar S; Zhao J; Talluri S; Buon L; Mu S; Potluri LB; Liao C; Shi J; Chakraborty C; Gonzalez GB; Tai YT; Patel J; Pal J; Mashimo H; Samur MK; Munshi NC; Shammas MA
Gastroenterology; 2023 Aug; 165(2):357-373. PubMed ID: 37178737
[TBL] [Abstract] [Full Text] [Related]
7. YTHDC2 Retards Cell Proliferation and Triggers Apoptosis in Papillary Thyroid cancer by Regulating cyld-Mediated Inactivation of Akt Signaling.
Zhou G; Wang S
Appl Biochem Biotechnol; 2024 Jan; 196(1):588-603. PubMed ID: 37162682
[TBL] [Abstract] [Full Text] [Related]
8. Long-Term Risk of Being Bedridden in Elderly Patients Who Underwent Oncologic Surgery: A Retrospective Study Using a Japanese Claims Database.
Konishi T; Sasabuchi Y; Matsui H; Tanabe M; Seto Y; Yasunaga H
Ann Surg Oncol; 2023 Aug; 30(8):4604-4612. PubMed ID: 37149549
[TBL] [Abstract] [Full Text] [Related]
9. Frequency and distribution of BRCA1/BRCA2 large genomic rearrangements in Turkish population with breast cancer.
Akin Duman T; Ozturk FN
J Hum Genet; 2023 Jul; 68(7):485-490. PubMed ID: 36864289
[TBL] [Abstract] [Full Text] [Related]
10. Distance to radiation therapy facility influences surgery type among older women with early-stage breast cancer.
Shrestha P; Chu QD; Hsieh MC; Yi Y; Peters ES; Trapido E; Yu Q; Ferguson T; Wu XC
Cancer Med; 2023 Mar; 12(6):6842-6852. PubMed ID: 36495041
[TBL] [Abstract] [Full Text] [Related]
11. Anticancer potential of Marina Crystal Minerals (MCM) against the growth of murine mammary adenocarcinoma cells in vivo.
Ghoneum M; Alaa El-Dein M; Badr El-Din NK
Biomed Pharmacother; 2023 Jan; 157():113975. PubMed ID: 36371853
[TBL] [Abstract] [Full Text] [Related]
12. Genistin modulates high-mobility group box protein 1 (HMGB1) and nuclear factor kappa-B (NF-κB) in Ehrlich-ascites-carcinoma-bearing mice.
Saleh MA; Antar SA; Abdo W; Ashour A; Zaki AA
Environ Sci Pollut Res Int; 2023 Jan; 30(1):966-978. PubMed ID: 35907070
[TBL] [Abstract] [Full Text] [Related]
13. Anticancer activity of chicken cathelicidin peptides against different types of cancer.
Mahmoud MM; Alenezi M; Al-Hejin AM; Abujamel TS; Aljoud F; Noorwali A; Awad IA; Alkhaled M; Yacoub HA
Mol Biol Rep; 2022 Jun; 49(6):4321-4339. PubMed ID: 35449320
[TBL] [Abstract] [Full Text] [Related]
14. Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?
Lavoro A; Scalisi A; Candido S; Zanghì GN; Rizzo R; Gattuso G; Caruso G; Libra M; Falzone L
Int J Oncol; 2022 May; 60(5):. PubMed ID: 35383859
[TBL] [Abstract] [Full Text] [Related]
15. The influence of antioxidant dietary-derived polyphenolic combination on breast cancer: Molecular study.
Alqarni AA; Alamoudi AA; Allam RM; Ajabnoor GM; Harakeh SM; Al-Abd AM
Biomed Pharmacother; 2022 May; 149():112835. PubMed ID: 35325850
[TBL] [Abstract] [Full Text] [Related]
16. Hydrazonoyl chlorides possess promising antitumor properties.
El Gendy MAM; Hassanein H; Saleh FM; Karimi-Busheri F; Fanta M; Yang X; Tawfik D; Morsy S; Fahmy M; Hemid M; Abdel Azeiz M; Fared A; Weinfeld M
Life Sci; 2022 Apr; 295():120380. PubMed ID: 35143825
[TBL] [Abstract] [Full Text] [Related]
17. Hypnea musciformis-mediated Ag/AgCl-NPs inhibit pathogenic bacteria, HCT-116 and MCF-7 cells' growth in vitro and Ehrlich ascites carcinoma cells in vivo in mice.
Ghose R; Asaduzzaman AKM; Hasan I; Kabir SR
IET Nanobiotechnol; 2022 Apr; 16(2):49-60. PubMed ID: 35015917
[TBL] [Abstract] [Full Text] [Related]
18. Low Expression of Long Noncoding RNA SLC26A4 Antisense RNA 1 Is an Independent Prognostic Biomarker and Correlate of Immune Infiltrates in breast cancer.
Yi W; Shen H; Sun D; Xu Y; Feng Y; Li D; Wang C
Med Sci Monit; 2021 Dec; 27():e934522. PubMed ID: 34880202
[TBL] [Abstract] [Full Text] [Related]
19. A new insight to deformability correlation of circulating tumor cells with metastatic behavior by application of a new deformability-based microfluidic chip.
Hakim M; Khorasheh F; Alemzadeh I; Vossoughi M
Anal Chim Acta; 2021 Nov; 1186():339115. PubMed ID: 34756251
[TBL] [Abstract] [Full Text] [Related]
20. Ellagic acid-loaded, tween 80-coated, chitosan nanoparticles as a promising therapeutic approach against breast cancer: In-vitro and in-vivo study.
Kaur H; Ghosh S; Kumar P; Basu B; Nagpal K
Life Sci; 2021 Nov; 284():119927. PubMed ID: 34492262
[TBL] [Abstract] [Full Text] [Related]
[Next]
